Senior insider sale
Chief Executive Officer at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$38.53M
245.09K shares
What this filing means
GORMAN KEVIN CHARLES plans to sell 245.09K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $38.53M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/19/2026ACC: 0001950047-26-004764
DirectorOfficer· Chief Executive Officer
Since Feb 2019
245.09K
Shares to sell
$38.53M
Approx. market value
245.09K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
5/19/2026
205.09KPreviously Vested RSUs & PSUs
N/A
2/1/2020
40KTotal acquired245.09K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/19/2026 | Exercise of Stock Options Cash | 205.09K | — |
2/1/2020 | Previously Vested RSUs & PSUs N/A | 40K | — |
| Total | 245.09K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
245.09K
Market value
$38.53M
5/19/2026
Total
Units
245.09K
Value
$38.53M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/19/2026 | 245.09K | $38.53M | NASDAQ | Planned |
| Total | 245.09K | $38.53M | ||